Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ParentsTREAT: Parent-to-Child Nasal Microbiota Transplant
NCT05695196Phase 1Active, not recruiting
- Sponsor
- Johns Hopkins University
- Start
- Oct 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 1, randomised trial in Staphylococcus aureus infection and neonatal infection (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Neonatal nasal microbiome diversity at Day 14. Started Oct 2023; status: active, not recruiting.
02
Conditions
Staphylococcus aureus infectionneonatal infection
Beyond the preview
Go deeper on NCT05695196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05695196.